+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

P2X7 Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

P2X7 Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
IL-6 Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

IL-6 Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Selectin Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Selectin Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Broad Spectrum Chemokine Inhibitor (BSCIs) - Pipeline Insight, 2025 - Product Thumbnail Image

Broad Spectrum Chemokine Inhibitor (BSCIs) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Bradykinin Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Bradykinin Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Still's Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Still's Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adult-Onset Still Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Adult-Onset Still Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Systemic Inflammatory Response Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Systemic Inflammatory Response Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Allergy Sinus Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Allergy Sinus Pain - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Acute Gout Flare - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Gout Flare - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hair Diseases - Pipeline Insight, 2025 - Product Thumbnail Image

Hair Diseases - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
PD-1 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

PD-1 Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Dense Deposit Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Dense Deposit Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Cryoprin-Associated Periodic Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Cryoprin-Associated Periodic Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Gluten Sensitivity - Pipeline Insight, 2025 - Product Thumbnail Image

Gluten Sensitivity - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Myofibroblasts - Pipeline Insight, 2025 - Product Thumbnail Image

Myofibroblasts - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Acquired Immunodeficiency Syndrome (AIDS) - Pipeline Insight, 2025 - Product Thumbnail Image

Acquired Immunodeficiency Syndrome (AIDS) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more